Six new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON, Nov. 4, 2025 /PRNewswire/ — DaVita, a steadfast leader in kidney care research and… Read more

Largest kidney care research arm advances science to inform care delivery DENVER, Aug. 27, 2025 /PRNewswire/ — As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud… Read more

DENVER and SAN DIEGO, Oct. 23, 2024 /PRNewswire/ — DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative… Read more

Company highlights major milestones achieved over the past year DENVER, Jan. 31, 2023 /PRNewswire/ — Today, DaVita recognizes the impact its employees, known as teammates, had on kidney care in 2022. Over the last year,… Read more

This year’s research centered on advancements in kidney transplantation and equity in patient care DaVita addresses equitable access to breakthrough trials and decentralized research by introducing new Chronic Kidney Disease… Read more

Research further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection DENVER, Feb. 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson… Read more

Company highlights major milestones achieved over the past year DENVER, Jan. 12, 2022 /PRNewswire/ — DaVita today celebrated its teammates (employees) for their contributions that helped improve the lives of kidney patients, advance innovation… Read more

Research supports vaccination as an important clinical strategy to help protect vulnerable patients from virus infection. DENVER, Nov. 29, 2021 /PRNewswire/ — Dialysis patients who received mRNA COVID-19 vaccines had a lower risk… Read more

Groundbreaking research holds promise for new clinical management techniques and understanding of vaccine immune response in kidney patients DENVER, Nov. 4, 2021 – DaVita Clinical Research (DCR) will present eight… Read more

Latest research supports improvements in care delivery and patient outcomes DENVER, Oct. 22, 2020 /PRNewswire/ — DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the… Read more